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Context:Elevated IL-1 receptor antagonist (IL-1Ra) concentrations are associatedwith obesity, insulin
resistance, and cardiovascular disease (CVD) risk in adults.
Objective: To determine if serum IL-1Ra and high-sensitivity C-reactive protein (hs-CRP) levels are
associated with markers of reduced insulin sensitivity (IS) and serum lipids in 12-year-old children.
Design and Participants: Of 191 children (n = 109 girls), 78 were categorized as having had birth
weight and length appropriate for gestational age (AGA), 69 were small for gestational age, and 44 were
AGAand frompreeclamptic pregnancies. Serummarkers of low-grade inflammation, IS, and lipids were
measured. Quantitative Insulin Sensitivity Check Index (QUICKI) was calculated.
Results: Mean serum IL-1Ra levels did not differ between the sexes or among the gestational cate-
gories. Children in the highest IL-1Ra tertile had lower QUICKI, IGF-binding protein-1, SHBG, and
high-density lipoprotein cholesterol values; and higher body mass index (BMI), waist circumference to
height ratio (WHtR), and serum insulin, hs-CRP, leptin, and triglyceride concentrations than those in
the lowest IL-1Ra tertile. Logistic regression analysis showed higher serum hs-CRP and leptin levels,
and WHtR were associated with high serum IL-1Ra levels. IL-1Ra concentration could be used to
discriminate the children with lowest IS (area under the curve, 0.68; P, 0.001); hs-CRP level could not.
Conclusion: Children with the highest IL-1Ra levels had lower IS, higher hs-CRP levels and BMI,
and a less favorable lipid profile than those with the lowest IL-1Ra levels, suggesting that high IL-1Ra
concentrations may be associated with increased CVD risk in 12-year-old children.
Copyright © 2018 Endocrine Society
This article has been published under the terms of the Creative Commons Attribution Non-
Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Adipose tissue is a metabolically active organ that secretes a variety of adipocytokines, which
are able to modulate immunological responses, energy homeostasis, adipogenesis, and in-
sulin sensitivity (IS) [1]. Metabolic stress in the white visceral adipose tissue causes chronic
subclinical inflammation, which may induce activation of the innate immune system, leading
Abbreviations: AGA, appropriate for gestational age; apoB, apolipoprotein-B; AUC, area under the receiver operating characteristic
curve; BMI, bodymass index; BMIadj, sex- and adult age–adjusted bodymass index; CV, coefficient of variation; CVD, cardiovascular
disease; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; IGFBP-1, IGF binding protein-1;
IL-1Ra, IL-1 receptor antagonist; IS, insulin sensitivity; PRE, preeclamptic pregnancy; QUICKI, Quantitative Insulin Sensitivity
Check Index; ROC, receiver operating characteristic; SGA, small for gestational age; WHtR, waist circumference to height ratio.
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to dysregulated adipocytokine synthesis, insulin resistance, b-cell dysfunction, and type 2
diabetes [1–4]. Furthermore, proinflammatory cytokines contribute to vascular endothelial
dysfunction and, finally, to atherosclerotic cardiovascular disease (CVD) [4, 5].
The IL-1 cytokine family is a critical regulator of the innate immune responses [3, 5, 6]. It
consists of 11 members [6], almost all of which are involved in visceral obesity-associated
inflammation [3]. The proinflammatory cytokine IL-1b induces secretion of other proin-
flammatory cytokines, inhibits b-cell function, destroys b-cells, and promotes insulin re-
sistance [3, 4]. Its natural antagonist is the adipose tissue–derived cytokine IL-1 receptor
antagonist (IL-1Ra) [7], which acts by blocking the binding site of IL-1b at the IL-1 receptor
[6]. IL-1Ra synthesis is induced by many inflammatory factors, including the members of the
IL-1 family [3].
IL-1b induces IL-1Ra production; thus, upregulated IL-1Ra levels are considered to reflect
higher IL-1b activity [8] and predispose to insulin resistance and type 2 diabetes [3]. In
adults, elevated IL-1Ra concentrations are associated with risk for type 2 diabetes [4, 8–10],
the metabolic syndrome and obesity [3], essential hypertension [11] and CVD [4, 8]. Fur-
thermore, increased IL-1Ra concentrations in obesity in childhood are a sign of low-grade
inflammation [12]. Moreover, IL-1Ra was considered the most sensitive marker of cytokine
response in the prediabetic state in the offspring of patients with type 2 diabetes [9].
The aim of the current study was to determine whether serum IL-1Ra concentrations are
associated with other markers of low-grade inflammation, reduced IS, or unfavorable lipid
profile in 12-year-old children. Furthermore, we investigated whether IL-1Ra concentrations
are associated with low birth weight or exposure to maternal preeclampsia, which are
considered to independently predispose to later metabolic and CVDs [13–15]. Finally, we
compared concentrations of IL-1Ra with high-sensitivity C-reactive protein (hs-CRP) in
terms of detecting reduced IS and unfavorable lipid profile.
1. Material and Methods
A. Definitions
Preeclampsia was defined as the development of hypertension and proteinuria (.300 mg of
urinary protein in 24 hours) after 20 weeks of gestation [16]. Hypertension was defined as
blood pressure.140/90 mm Hg or a rise of$30/15 mm Hg from the baseline level confirmed
by two measurements at least 6 hours apart. Birth at or after week 37 and before the 42nd
week of gestation was considered full term; birth before the 37th week of gestation (calculated
from the beginning of the last menstruation) was considered preterm. Small for gestational
age (SGA) was defined as birth weight and/or length .2 SDs below the respective mean for
the gestational age and sex. Appropriate for gestational age (AGA) was defined as birth
weight and birth length equal to or above 22 SDs and equal to or below +2 SDs of the re-
spective mean for gestational age and sex [17].
B. Subjects
This study population consisted of a cohort of 191 12-year-old children who originally were
recruited for a study investigating the metabolic consequences of either being born SGA or
being born after a preeclamptic pregnancy (PRE). Of this cohort, 109 were girls, 69 were born
SGA, and 44 were born after a PRE as AGA. The median of the gestational ages was
38.0 weeks (range, 28 to 42 weeks). The extremely preterm children born before week 28 of
gestation were excluded from the study. None of the participating children was exposed to
exogenous glucocorticoids prenatally. All children were born at Kuopio University Hospital,
Kuopio, Finland, during 22months between 1984 and 1986. The study protocol was approved
by the Research Ethics Committee of Kuopio University Hospital. Informed written consent
was obtained from the child and the parents.
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C. Methods
The perinatal data, anthropometric measures, and ambulatory blood pressure values at
12 years age have been described previously for the SGA [18, 19] and PRE children [20, 21].
Pubertal development was classified as Tanner stages according to breast development in
girls and genital development in boys. Body mass index (BMI; calculated as weight in ki-
lograms divided by height in meters squared) and sex- and adult age–adjusted BMI (BMIadj;
corresponding to the BMI values at the age of 18 years [22]) were calculated. Waist cir-
cumference to height ratio (WHtR) was calculated by dividing waist circumference (in
centimeters) by height (in centimeters). Perinatal characteristics, anthropometric measures,
and pubertal development at the age of 12 years in the whole population are presented in
Table 1.
C-1. Laboratory methods
Blood samples were taken in the morning, between 9:00 AM and 10:00 AM, after an overnight
fast. An IV cannula was placed in the antecubital vein for blood sampling. After the child had
rested for 1 hour in a recumbent position, blood samples were collected through the cannula.
Serum specimens were immediately frozen and stored at 270°C until analyzed.
Serum IL-1Ra concentrations weremeasured by ELISA (human IL-1ra Quantikine ELISA
Kit; R&D Systems, Minneapolis, MN). The intra- and interassay coefficients of variation
Table 1. Anthropometric Characteristics of the Study Population at Birth and at Age 12 Years
Variable All (N = 191) Girls (n = 109) Boys (n = 82) P Valuea
At birth
Gestational age, wk 0.043
Mean 37.7 38.1 37.2
Median 38.0 39.0 38.0
Range 28–42 29–42 28–42
Weight, g 2773 (2666–2881) 2736 (2586–2886) 2823 (2669–2978) 0.482
Weight (SDS) 21.13 (21.33 to20.94) 21.27 (21.55 to21.00) 20.95 (21.21 to20.69) 0.070
Length, cm 47.3 (46.8–47.8) 47.0 (46.3–47.8) 47.7 (46.9–48.5) 0.319
Length (SDS) 20.87 (21.08 to20.66) 21.02 (-1.31 to -0.74) 20.67 (20.98 to20.36) 0.091
Age 12 years
Age, y 12.26 (12.23–12.29) 12.27 (12.22–12.31) 12.26 (12.22–12.29) 0.970
Weight, kg 44.13 (42.61–45.65) 44.35 (42.27–46.43) 43.83 (41.57–46.09) 0.835
BMIadj, kg/m2 21.44 (20.89–21.99) 20.94 (20.26–21.61) 22.10 (21.21–23.00) 0.060
Height, cm 153.2 (152.1–154.2) 153.9 (152.4–155.4) 152.2 (150.5–153.8) 0.208
Height (SDS) 0.26 (0.12–0.41) 0.16 (20.04 to 0.36) 0.40 (0.18–0.62) 0.061
WHtR 0.002
Mean 0.43 0.42 0.44
Median 0.42 0.41 0.43
Range 0.35–0.63 0.35–0.63 0.36–0.63
Pubertal developmentb
(early or late stage), no.
106/85 38/71 68/14 ,0.001c
Tanner B/G stage, no. ,0.001c
1 40 14 26
2 66 24 42
3 50 38 12
4 27 25 2
5 8 8 0
Data are given as mean (95% CI) or, for the variables with skew distributions, as mean, median and range.
Abbreviations: B/G, breast/genital development; SDS, SD score.
aMann-Whitney U test for the differences between the girls and boys.
bEarly stage of puberty: breast or genital development scores, 1–2; late stage of puberty: breast or genital devel-
opment scores 3–5.
cx2 test for the differences between the girls and boys.
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(CVs) for IL-1Ra were 3.6% and 5.7%, respectively. Serum hs-CRP concentrations were
determined by a photometric immunoturbidimetric method (Konelab 20XT Clinical
Chemistry Analyzer; Thermo Fisher Scientific, Vantaa, Finland), and the interassay CVs
were 5.0% at 0.78 mg/L and 2.3% at 2.55 mg/L. Serum insulin concentrations were de-
termined by RIA (Phadeseph Insulin RIA; Pharmacia & Upjohn Diagnostics, Uppsala,
Sweden); the intra- and interassay CVs were 5.3% and 7.6%, respectively. Blood glucose
concentrations were analyzed by a glucose oxidase method (Enzyme Electrode; Nova Bio-
medical, Waltham, MA), and the respective CVs were 3% and 5%. Serum high-density li-
poprotein cholesterol (HDL-C) and triglyceride levels were measured enzymatically by an
automatic photometric method (Roche Molecular Biochemicals, Mannheim, Germany); the
interassay CVs for HDL-C were 4.1% at 0.84 mM and 3.8% at 1.69 mM, and for triglycerides
were 3.2% at 1.23 mM and 1.6% at 2.45 mM. Serum IGF-binding protein-1 (IGFBP-1)
concentration was analyzed by ELISA (DSL-10-7800 ACTIVE Total IGFBP-1 ELISA; Di-
agnostic Systems Laboratories, Webster, TX). The intra- and interassay CVs for IGFBP-1
were 2.5% and 6.8%, respectively. Serum SHBG level was measured by the AutoDELFIA
SHBG time-resolved fluoroimmunoassaymethod (Perkin Elmer Life SciencesWallac, Turku,
Finland). The intra- and interassay CVs were 4.0% and 2.6%, respectively. Serum leptin and
adiponectin concentrations were analyzed by ELISA (Quantikine DLP00 and Quantikine
DRP300; R&D Systems); intra- and interassay CVs for leptin were 3.2% and 2.5% to 4.7%,
and for adiponectin were 3.5% and 5.8% to 6.9%. Serum apolipoprotein-B (apoB) level was
also analyzed by immunoturbidimetry (Konelab 20XT Clinical Chemistry Analyzer; Thermo
Fisher Scientific); the interassay CV was 1.1%. Quantitative Insulin Sensitivity Check Index
(QUICKI) was calculated as 1/[log (fasting insulin, measured in microunits per milliliter) +
log (fasting glucose, measured in milligrams per deciliter)] [23].
D. Statistical Analyses
Data were analyzed using the statistical program SPSS for Macintosh, version 24.0 (IBM,
Armonk, NY). All continuous variables were examined for normality with the Kolmogorov-
Smirnov test. Because most of the measured variables did not distribute normally, the
nonparametric Mann-Whitney U test was used for the comparisons between the continuous
variables, and the x2 test was used for the categorical variables. Analysis of covariance was
used to exclude the effects of confounding factors on the results. The Kruskal-Wallis test was
used in the comparisons of the lowest, middle and highest IL1-Ra tertiles. Adjusted P values
(Bonferroni correction) were reported in these analyses. Because of the skew distributions of
some variables, the median and range were reported in addition to the mean. Partial cor-
relation coefficients were calculated.
Logistic regression analyses were used to explore independent associating factors with
high serum levels of IL-1Ra or high levels of hs-CRP. Receiver operating characteristic (ROC)
curve analyses were used to explore whether IL-1Ra or hs-CRP concentrations could be used
to identify the children with the lowest QUICKI values. Multivariable regression analyses
were performed to evaluate the independent contributions of serum inflammatory markers
and BMIadj to IS and lipid variables. In parametric tests, skewed variables were either
logarithmically or square-root transformed before testing. P , 0.05 was accepted as sig-
nificant in all analyses. hs-CRP values .10 mg/L (n = 2 boys, n = 1 girl) were excluded from
the hs-CRP analyses because of the possibility of acute infections.
2. Results
A. Anthropometric Characteristics and Pubertal Development
At the age of 12 years, the boys had a higher WHtR than the girls (P , 0.002), whereas the
difference in BMIadj did not reach statistical significance (Table 1). Pubertal development
was more advanced in the girls than boys: 87% of the girls and 68% of the boys had pubertal
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signs (Tanner stage for breast development/genital development, $2; Table 1). Weight or
height did not differ significantly between the girls and boys. The children in the SGA group
were shorter and leaner compared with the those in the AGA and PRE groups in terms of
height SD scores and BMIadj (SGA vs AGA:20.19 and 0.63, P, 0.001; 20.33 and 22.14 kg/m2,
P = 0.034, respectively; and SGA vs PRE: 20.19 and 0.33, P = 0.022; 20.33 and 21.94 kg/m2,
P = 0.032, respectively, by Bonferroni-adjusted Kruskall-Wallis test). Pubertal development
did not differ among the SGA, AGA, or PRE subgroups or between the children born preterm
or at full term (data not shown).
B. Inflammation and Insulin Sensitivity Markers and Lipids
Themean concentrations of serum IL1-Ra or hs-CRP did not differ between the girls and boys
(Table 2). However, the girls had significantly higher serum insulin, leptin, and triglyceride
concentrations, and lower QUICKI, blood glucose, and serum IGFBP-1 values than the boys
(Table 2). The sex differences remained essentially similar even after adjustment for pubertal
developmental stage and BMIadj (performed by analysis of covariance; data not shown).
Serum IL-1Ra, hs-CRP, lipids, or ISmarkers (i.e., QUICKI, IGFBP-1, adiponectin, SHBG) did
not differ among the AGA, SGA, and PRE groups or between the children born at full term or
preterm (data not shown).
C. Factors Associated With Higher Serum IL-1Ra Concentrations
The children in the highest IL1-Ra tertile had significantly lower QUICKI, IGFBP-1, and
SHBG values, and higher values for BMIadj, WHtR, leptin, and hs-CRP when compared
with the children in the lower IL1-Ra tertiles (Table 3). Height SD scores did not differ
Table 2. Biochemical Parameters in the Whole Study Population
Variable All (N = 191) Girls (n = 109) Boys (n = 82) P Valuea
Serum IL-1Ra, pg/mL 0.610
Mean 285.9 274.4 301.1
Median 222.3 226.2 219.1
Range 31.1–1605.8 31.1–1151.2 94.0–1605.8
Serum hs-CRP, mg/L n = 187 n = 107 n = 80 0.170
Mean 0.64 0.50 0.82
Median 0.09 0.09 0.12
Range 0.09–9.43 0.09–5.52 0.09–9.43
Serum insulin, mU/L 10.2 (9.6–10.8) 11.1 (10.2–12.1) 8.9 (8.2–9.5) 0.001
Blood glucose, mmol/L 4.3 (4.3–4.4) 4.3 (4.2–4.3) 4.4 (4.3–4.5) 0.022
QUICKI 0.351 (0.348–0.354) 0.347 (0.342–0.352) 0.356 (0.351–0.361) 0.006
Serum IGFBP-1, mg/L 66.1 (61.0–71.3) 60.9 (54.3–67.5) 73.1 (65.0–81.3) 0.022
Serum SHBG, nmol/L 73.6 (68.9–78.3) 69.6 (63.7–75.5) 78.9 (71.4–86.5) 0.097
Serum leptin, mg/L ,0.001
Mean 15.1 18.0 11.2
Median 9.3 12.3 6.8
Range 0.3–101.5 0.3–101.5 0.4–58.8
Serum adiponectin, mg/L 11.0 (10.1–11.8) 11.2 (10.1–12.3) 10.7 (9.4–12.1) 0.504
Serum triglycerides,
mmol/L
0.92 (0.86–0.98) 0.98 (0.90–1.07) 0.83 (0.75–0.91) 0.010
Serum HDL-C, mmol/L 1.32 (1.28–1.36) 1.30 (1.25–1.35) 1.36 (1.29–1.42) 0.153
Serum apoB, g/L 0.71 (0.69–0.74); n = 189 0.73 (0.69–0.76); n = 108 0.70 (0.66–0.75); n = 81 0.228
24-h systolic BP, mm Hg 117 (116–118); n = 179 116 (114–117); n = 100 118 (116–119); n = 79 0.375b
24-h diastolic BP, mm Hg 69 (68–69); n = 179 68 (67–69); n = 100 69 (68–70); n = 79 0.326b
Data given as mean (95% CI) or, for the variables with skew distributions, as mean, median and range.
Abbreviation: BP, blood pressure.
aMann-Whitney U-test for the differences between the girls and boys.
bAnalysis of covariance adjusted for BMIadj and height (SD score).
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significantly between these groups (0.01, 0.30, and 0.49 in the lowest, middle, and highest
IL1-Ra tertiles, respectively, P = 0.060 by the Kruskall-Wallis test). Furthermore, the lowest
serum HDL-C and the highest insulin and triglyceride concentrations were found in the
highest IL1-Ra tertile and were significantly different from those in the lowest IL1-Ra tertile
(Table 3). The concentrations of blood glucose, serum apoB, or adiponectin were not sig-
nificantly different among the IL1-Ra tertiles. Sex distribution and pubertal development did
not differ significantly among the IL-1Ra tertiles (Table 3). In sex-specific tertile analyses, the
differences remained similar in the girls but were attenuated in the boys. However, the














Mean 0.19 0.33 1.45 ,0.001
Median 0.09 0.09 0.70 ,0.001b
Range 0.09–2.13 0.09–5.52 0.09-9.43; n = 59
Serum insulin, mU/L 9.0 (8.0–10.0) 9.8 (8.9–10.6) 11.8 (10.5–13.0) ,0.001
Blood glucose, mmol/L 4.3 (4.2–4.4) 4.3 (4.3–4.4) 4.4 (4.3–4.4) 0.969
QUICKI 0.358 (0.352–0.364) 0.352 (0.346–0.357) 0.343 (0.337–0.349) 0.001
0.046b
Serum IGFBP-1, mg/L 74.7 (65.1–84.2) 67.0 (59.9–74.1) 56.6 (46.6–66.5) 0.001
0.030b
Serum SHBG, nmol/L 85.2 (77.0–93.4) 79.0 (71.7–86.3) 56.3 (49.0–63.7) ,0.001
,0.001b
Serum leptin, mg/L
Mean 9.4 10.7 25.3 ,0.001
Median 4.4 8.3 23.0 ,0.001b
Range 0.3–52.4 0.9–41.0 0.8–101.5
Serum adiponectin, mg/L 10.9 (9.4–12.3) 11.7 (9.9–13.4) 10.4 (9.1–11.7) 0.700
Serum triglycerides, mmol/L 0.81 (0.73–0.88) 0.95 (0.84–1.07) 0.99 (0.88–1.11) 0.037
Serum HDL cholesterol,
mmol/L
1.40 (1.33–1.47) 1.31 (1.24–1.38) 1.26 (1.20–1.32) 0.016
Serum apoB, g/L 0.69 (0.64–0.74); n = 63 0.74 (0.69–0.78) 0.72 (0.67–0.76); n = 62 0.170
BMIadj, kg/m2 19.5 (18.9–20.1) 20.5 (19.8–21.3) 24.3 (23.3–25.4) ,0.001
,0.001b
WHtR 0.41 (0.40–0.41) 0.42 (0.41–0.43) 0.47 (0.45–0.49) ,0.001
,0.001b
24h-systolic BP, mm Hg 116 (114–118); n = 60 117 (114–119); n = 61 118 (116–120); n = 58 0.449c
24-h diastolic BP, mm Hg 68 (66–69); n = 60 69 (68–70); n = 61 69 (68–70); n = 58 0.244c
Sex, F/M, no. 36/28 42/22 31/32 0.172d
Pubertal development,e
early or late stage, no.
39/25 31/33 36/27 0.345d
Tanner B/G stage 0.652d
1 11 (4/7) 12 (7/5) 17 (3/14)
2 28 (10/18) 19 (9/10) 19 (5/14)
3 14 (12/2) 21(15/6) 15 (11/4)
4 9 (8/1) 9 (8/1) 9 (9/0)
5 2 (2/0) 3 (3/0) 3 (3/0)
Data given as mean (95% CI); medians and ranges are given for the variables with skew distributions.
Abbreviation: B/G, breast/genital development.
aIndependent-samples Kruskal-Wallis test, Bonferroni-adjusted P value, comparison between the lowest and the
highest IL-1Ra tertile.
bIndependent-samples Kruskal-Wallis test for the differences, Bonferroni-adjusted P value, comparison between the
middle and the highest IL-1Ra tertile.
cAnalysis of covariance adjusted for BMIadj and height (SDS).
dx2 test.
eEarly stage of puberty: breast or genital scores 1–2; late stage of puberty: breast or genital scores 3–5.
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associations maintained the same trend in the boys as detected in the girls and in the whole
study population (data not shown). In a binary logistic regression analysis adjusted for sex,
pubertal development (early or late stage), birth weight SD score, and maternal PRE
pregnancy history, higher leptin and hs-CRP concentrations, and WHtR associated in-
dependently with high IL-1Ra concentration. A 1-mg/L increase in leptin concentration, a
0.1-mg/L increase in hs-CRP concentration, and a 0.01 unit increase inWHtRwere associated
with a 1.08-, 1.30-, and 1.20-fold risk of a high IL-1Ra value, respectively (Table 4).
D. Factors Associated With Higher Serum hs-CRP Concentrations
The children in the higher hs-CRP group (i.e., hs-CRP concentration.0.09 mg/L; n = 87) had
higher BMIadj (22.6 vs 20.4 kg/m2; P = 0.002), WHtR (0.45 vs 0.41; P , 0.001), and higher
serum IL-1Ra (363.7 vs 207.9 pg/mL; P , 0.001), leptin (19.7 vs 11.2 mg/L; P = 0.011), and
apoB (0.75 vs 0.68 g/L; P = 0.018) concentrations, and lower serum SHBG concentrations
(66.0 vs 81.5 nmol/L; P , 0.001) than the children with lower hs-CRP (hs-CRP concentra-
tion #0.09 mg/L; n = 100). Pubertal development or sex distribution did not differ signifi-
cantly between these groups.
In BMIadj-adjusted analyses, serum hs-CRP concentration correlated positively with
serum IL-1Ra concentration in the whole study population (r = 0.306; P, 0.001; n = 184) and
when the sexes were analyzed separately (girls: r = 0.250, P = 0.009, n = 105; boys: r = 0.401,
P , 0.001, n = 79). A similar correlation between hs-CRP and IL-1Ra levels was found in
WHtR-adjusted analyses in the whole study population (r = 0.280; P, 0.001; n = 184) and in
the boys (r = 0.403; P, 0.001; n = 79), whereas the association in the girls was attenuated (r =
0.140; P = 0.151; n = 105). In a binary logistic regression analysis (adjusted for sex, early or
late pubertal development stage, birthweight SD score,WHtR, andmaternal PRE pregnancy
history), higher IL-1Ra (OR, 1.09; 95% CI, 1.05 to 1.14; P , 0.001) and apoB ( OR, 1.31; 95%
CI, 1.08 to 1.60; P = 0.006) levels were associated independently with high serum levels of hs-
CRP. The other covariates (i.e., serum HDL-C, leptin, and SHBG) were not independently
associated with high hs-CRP level in this analysis (data not shown). This model explained
37.8% of the variation in the dependent variable (i.e., high hs-CRP level).
E. IL-1Ra and hs-CRP as Markers of Reduced Insulin Sensitivity and Unfavorable
Lipid Profile
An ROC curve analysis was performed to compare IL-1Ra and hs-CRP levels as markers by
which to identify the children with the lowest QUICKI values. The cut point of IL-1Ra
level$226.6 pg/mL had a sensitivity of 72% and specificity of 64% [area under the ROC curve
(AUC) for IL-1Ra, 0.676; 95% CI, 0.595 to 0.757; P , 0.001] to detect the children with the
lowest QUICKI values. BMIadj rose slightly above IL-1Ra in ability to discriminate the
children with the lowest IS (AUC for BMIadj, 0.691; 95% CI, 0.614 to 0.768; P , 0.001),
whereas IL-1Ra was a more reliable marker than WHtR (AUC for WHtR, 0.626; 95% CI,
Table 4. Factors Associating With High IL-1Ra (Highest IL-1Ra Tertile, n = 56) in the Whole
Study Population
Covariate Regression Coefficient Significance OR 95% CI for OR
High serum hs-CRP (0.1 mg/L) 0.259 ,0.001 1.30 1.13–1.49
High serum leptin, mg/L 0.081 0.003 1.08 1.03–1.14
High WHtR (0.01 units) 0.183 0.030 1.20 1.02–1.42
High blood glucose (0.1 mmol/L) 0.076 0.423 1.08 0.90–1.30
High serum triglyceride levels (0.1 mmol/L) 0.106 0.095 1.11 0.98–1.26
Highest IL-1Ra tertile, n = 56. Results of the binary logistic regression analysis (n = 181) adjusted for sex, pubertal
stage (Tanner stages of breast/genital development 1–2/3–5), birth weight (SD score) and maternal PRE pregnancy
history; variation explained by the model 68.6%.
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0.540 to 0.713; P = 0.004). The cut point of hs-CRP level $0.69 mg/L had a sensitivity of 31%
and a specificity of 85%, with no statistical significance (AUC for hs-CRP, 0.541; 95%CI, 0.450
to 0.632; P = 0.361). Levels of IL-1Ra and hs-CRP failed to be useful in detecting the children
with the highest triglyceride and lowest HDL-C concentrations (data not shown).
Finally, independent contributions of IL-1Ra, hs-CRP, and BMIadj to the variance in IS
and lipid variables were evaluated in multivariable regression models (adjusted for sex and
pubertal developmental stage). In these analyses, only BMIadj could significantly predict low
IS (measured by QUICKI) or HDL-C level, whereas serum IL-1Ra and hs-CRP levels had no
independent association with them (Table 5). The positive association between BMIadj and
triglycerides was significant when hs-CRP was entered in the model (Table 5).
3. Discussion
The results of this study revealed that the children with the highest serum IL-1Ra con-
centrations had lower IS, higher serum leptin and hs-CRP levels, and a less favorable lipid
profile than the children with lower serum IL-1Ra values. In a logistic regression analysis,
high leptin, hs-CRP, andWHtR values associated independently with high IL-1Ra level. The
ROC curve analysis showed that IL-1Ra level had a weak, but statistically significant ability
to predict low IS estimated by QUICKI. However, in a multivariable regression model, IL-
1Ra level had no independent association with IS.
Insulin resistance is associated with altered levels of cytokines, especially in visceral
adipose tissue [1, 3]. In obesity, adipose tissue macrophages release IL-1b, which inhibits
adipogenesis, impairs insulin signaling in adipocytes, and increases insulin resistance [4].
The secreted form of IL-1Ra, produced particularly by monocytes, macrophages, dendritic
cells, neutrophils, and epithelial cells in the adipose tissue [24], is a natural counterregulator
of IL-1b [3, 6, 7]. Its circulating concentrations are .100-fold higher compared with those of
IL-1b [6]. Elevated IL-1Ra concentrations have been observed up to 13 years before the onset
of type 2 diabetes [4] and are associated with 10-year diabetes risk [25], but they diminish in
patients with longstanding type 2 diabetes [26]. In the study of Grossmann et al. [10] in-
cluding .15,000 adults, IL-1Ra concentrations gradually increased from patients with
normoglycemia to those with prediabetes and further in those with type 2 diabetes.
Several studies have reported a positive correlation between IL-1Ra concentration and
BMI, lean body mass, waist circumference, insulin, and insulin resistance indexes [9, 12, 27].
Table 5. Multivariable Regression Analysis of Serum Inflammatory Markers, Adiposity Variables, and
Insulin Sensitivity Markers
Model/Dependent Variable Independent Variable r2a b P Value
Model 1, n = 191
QUICKI IL-1Ra 0.270 20.015 0.843
BMIadj 20.456 ,0.001
Triglyceride levels IL-1Ra 0.104 0.145 0.076
BMIadj 0.154 0.070
HDL-C level IL-1Ra 0.140 20.011 0.893
BMIadj 20.256 0.002
Model 2, n = 187
QUICKI hs-CRP 0.272 20.016 0.811
BMIadj 20.461 ,0.001
Triglyceride levels hs-CRP 0.090 0.085 0.259
BMIadj 0.187 0.018
HDL-C level hs-CRP 0.151 20.122 0.095
BMIadj 20.211 0.006
Sex and pubertal developmental stage (breast/genital development 1–5) were entered as covariates. Skewed var-
iables were logarithmically or square root–transformed before testing.
aThe variance explained by the model.
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Our study findings are in line with results of these studies: The children with the highest IL-
1Ra concentrations had higher BMIadj and WHtR than those with lower IL-1Ra concen-
trations, and a similar sex distribution and pubertal developmental stage. Furthermore, in a
binary logistic regression analysis, higher WHtR was associated with high IL-1Ra concen-
tration. The children in the highest IL-1Ra tertile had also higher serum insulin and lower
QUICKI, serum IGFBP-1 and SHBG values. Circulating IGFBP-1 and SHBG levels have
been associated with IS in healthy adults [28] and SHBG concentrations with IS and
metabolic risk during puberty [29].
The acute-phase protein CRP is a sensitive marker of the body’s inflammatory burden
and a downstream surrogate biomarker for IL-1b activity. Its high-sensitivity assays are
accurate enough to detect low-grade inflammation [5]. Thus, hs-CRP is used in CVD risk
prediction in adults [5] and youth [30]. In the current study, serum hs-CRP levels were higher
in children in the highest IL-1Ra tertile compared with those in the lower tertiles. In
addition, a positive association between IL-1Ra and hs-CRP levels was found independently
of BMIadj and WHtR. Recently, Bugge et al. [30] did not find any correlation between IL-
1Ra and CRP levels in Danish adolescents, whereas a positive correlation has been
demonstrated in prepubertal children [31] and in adults [32]. CRP levels associate with
central adiposity and BMI [30, 33, 34], and elevated CRP concentrations have been re-
ported in obese children and adolescents as a marker of subclinical inflammation [33, 34]. In
the current study, the childrenwith higher hs-CRP values had higher BMIadj andWHtR. They
also had higher serum IL-1Ra, leptin, and apoB, and lower SHBG concentrations. A negative
association between CRP and SHBG independently of BMI has been described in children and
adolescents [35].
Lipids regulate metabolism and inflammation, and hyperlipidemia induces, in part, pe-
ripheral tissue insulin resistance and contributes to the development of atherosclerosis [2]. In
this study, the children in the highest IL-1Ra tertile had lower HDL-C and higher triglyceride
concentrations compared with those in the lowest tertile. In line with this, circulating IL-1Ra
levels were independently associated with low HDL-C and high triglyceride concentrations in
healthy, nondiabetic men [27]. ApoB is considered to more accurately predict CVD risk than
total cholesterol and low-density lipoprotein cholesterol levels, because it indicates the total
number of atherogenic particles in circulation [36]. A positive associationbetween levels of apoB
and plasma IL-1Ra [37] or CRP [38] has been described in overweight or obese adults, and
elevated apoB levels have been reported in subjects with insulin resistance or type 2 diabetes
[39]. In this study of healthy 12-year-old children, we were not able to detect any difference in
serum apoB concentrations among the IL-1Ra tertiles. Instead, higher apoB concentrations
were found in children with higher hs-CRP levels than in those with lower hs-CRP levels, and
higher apoB level predicted higher hs-CRP level in a logistic regression analysis.
We used ROC curve analyses to compare IL-1Ra and hs-CRP levels as markers for
identifying the children with the lowest QUICKI values. IL-1Ra level had a relatively low, but
statistically significant discrimination value in detecting low IS, whereas hs-CRP level did
not distinguish the children with the lowest QUICKI value. These findings suggest IL-1Ra
may be a more sensitive serum marker than hs-CRP in detecting reduced IS in 12-year-old
children. However, the associations between IS and levels of IL-1Ra or hs-CRP were strongly
weight related: The regression analyses revealed that neither IL-1Ra nor hs-CRP levels had
an independent contribution to reduced IS. Furthermore, both IL-1Ra and hs-CRP levels
failed to predict low HDL-C and high triglyceride concentrations.
The satiety hormone leptin controls energy homeostasis and also regulates immune re-
sponse [2]. Its serum concentrations are associated with body-fat storage and circulating
inflammatory markers [1]. In the current study, the highest serum leptin concentrations
(with highest BMIadj and WHtR) were found in the highest IL-1Ra tertile and in the higher
hs-CRP group. In logistic regression analyses, both high leptin and high WHtR values were
associated independently with high IL-1Ra concentration, whereas they were not associated
with high hs-CRP concentration, which indicates IL-1Ra level may be amore sensitive serum
marker than hs-CRP level for obesity-related low-grade inflammation.
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In this study, we did not find a difference in serum IL-1Ra or hs-CRP concentrations
between girls and boys. This is in accordance with Cullup et al. [40], who reported that sex,
age, and menstruation status have no effect on IL-1Ra levels in healthy adults. Furthermore,
similar to our findings, Andersen et al. [41] did not find sex differences in CRP concentrations
among children 9 to 10 years old, whereas Cook et al. [33] reported that 10- to 11-year-old girls
had higher hs-CRP values compared with boys (without pubertal stage adjustment).
Low birth weight and maternal preeclampsia predispose to later cardiovascular morbidity
[13–15]. In the present cohort, we did not find any significant difference in serum IL-1Ra and
hs-CRP concentrations or other measured metabolic parameters in children in the SGA,
AGA, or PRE pregnancy groups. This finding suggests that other factors than small birth size
or maternal preeclampsia are more important in influencing the degree of low-grade in-
flammation in 12-year-old children.
The strengths of this study include detailed anthropometric data of the study subjects at
birth and at the age of 12 years, and numerous biochemical measurements. However, there
are also some weaknesses. The study age of 12 years is challenging because of the variable
timing in the pubertal development.We tried several ways to exclude the possible influence of
this on our results. We verified that the pubertal developmental stage did not differ sig-
nificantly among the compared subgroups (i.e., the IL-1Ra tertiles and the hs-CRP groups)
and adjusted the logistic regression analyses for the pubertal developmental stage. Despite
controlling several confounding factors, the one-time measurement of IS could be a potential
limitation in our study. Fasting insulin level alone or in combination with fasting glucose
level is not an optimal measure for assessing individual IS, but fasting insulin and glucose
values may be applicable in studies with well-defined cohorts [42]. We used QUICKI as a
surrogate marker of IS. QUICKI correlates quite well with the glucose clamp method [43].
Unfortunately, we did not have data on other factors influencing IS, such as dietary habits
and the frequency and intensity of exercise.
4. Conclusion
The children with the highest IL-1Ra concentrations had lower IS; higher serum hs-CRP,
BMIadj, and WHtR values; and a less favorable lipid profile than those with the lowest IL-
1Ra values. These findings suggest high IL-1Ra concentrations are associated with un-
favorable metabolic features in 12-year-old children. IL-1Ra concentration was a better
marker of low IS in the children than was hs-CRP concentration, but the real value of IL-1Ra
measurements in predicting CVD risk in children remains to be determined.
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